This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of Texas System, University of Cincinnati, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,640 
2 out of 556 
2 out of 915 
Years Active: 2021-2023
Title: Inventor Nira Ben-Jonathan: Pioneering Advances in Cancer Treatment
Introduction
Nira Ben-Jonathan is a notable inventor based in Cincinnati, OH, who has made significant contributions to the field of pharmaceuticals. Her innovative work focuses on developing small molecule prolactin receptor inhibitors, which hold promise in treating various disorders, including breast and prostate cancer.
Latest Patents
Nira holds two patents that specifically address the use of small molecule inhibitors (SMIs) of the prolactin receptor. These patents encompass pharmaceutical compositions and treatment methods designed for patients suffering from disorders characterized by increased expression or activation of the prolactin receptor. Disorders treated with these inventions include breast cancer, prostate cancer, and nociceptive pain disorders such as migraine headaches. The efficacy of these SMIs opens new avenues for therapeutic interventions and enhances patient care.
Career Highlights
Throughout her career, Nira has been associated with prestigious institutions, including the University of Cincinnati and the University of Texas System. Her roles in these universities have allowed her to collaborate with other experts in her field and contribute to groundbreaking research that bridges the gap between science and practical applications.
Collaborations
In her innovative journey, Nira has worked alongside talented individuals like Eric R. Hugo and Edward J. Merino. Collaborating with such professionals has enriched her research, enabling significant advancements in the understanding and treatment of disorders related to the prolactin receptor.
Conclusion
Nira Ben-Jonathan's contributions to the field of pharmaceuticals exemplify the importance of innovation in medicine. With her patents targeting crucial health issues, she continues to impact the lives of many patients through her research and development efforts. Her work not only reflects her dedication but also underscores the potential of small molecule inhibitors in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile